Target Corporation (ETR:DYH)

Elevation Oncology Balance Sheet

Financials in millions USD. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 3, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Cash & Equivalents	2,887	4,762	3,805	2,229	5,911	8,511
Trading Asset Securities	-	-	-	-	17	-
Cash & Short-Term Investments	2,887	4,762	3,805	2,229	5,928	8,511
Cash Growth	-19.89%	25.15%	70.70%	-62.40%	-30.35%	225.34%
Accounts Receivable	-	998	891	1,169	835	631
Other Receivables	-	543	513	526	518	504
Receivables	-	1,541	1,404	1,695	1,353	1,135
Inventory	13,048	12,740	11,886	13,499	13,902	10,653
Prepaid Expenses	-	226	201	188	170	171
Other Current Assets	1,824	185	202	235	220	286
Total Current Assets	17,759	19,454	17,498	17,846	21,573	20,756
Property, Plant & Equipment	36,921	36,785	36,458	34,169	30,737	29,106
Long-Term Investments	-	-	-	7	135	188
Goodwill	-	631	631	631	631	631
Other Intangible Assets	-	-	-	14	25	37
Other Long-Term Assets	1,505	899	769	668	710	530
Total Assets	56,185	57,769	55,356	53,335	53,811	51,248
Accounts Payable	11,823	13,053	12,098	13,487	15,478	12,859
Accrued Expenses	4,637	2,642	2,676	2,358	2,908	3,028
Current Portion of Long-Term Debt	1,142	1,500	997	1	63	1,056
Current Portion of Leases	358	489	448	425	362	299
Current Income Taxes Payable	-	334	113	-	-	-
Current Unearned Revenue	1,031	1,209	1,162	1,240	1,202	1,035
Other Current Liabilities	-	1,572	1,810	1,989	1,734	1,848
Total Current Liabilities	18,991	20,799	19,304	19,500	21,747	20,125
Long-Term Debt	14,399	12,279	13,028	14,147	11,582	9,770
Long-Term Leases	3,564	5,607	5,173	4,581	4,460	3,984
Long-Term Unearned Revenue	-	388	419	449	479	509
Long-Term Deferred Tax Liabilities	2,338	2,303	2,480	2,196	1,566	990
Other Long-Term Liabilities	1,946	1,696	1,487	1,193	1,105	1,373
Total Liabilities	41,238	43,103	41,924	42,103	40,984	36,808
Common Stock	38	38	38	38	39	42
Additional Paid-In Capital	7,011	6,996	6,761	6,608	6,421	6,329
Retained Earnings	8,360	8,090	7,093	5,005	6,920	8,825
Comprehensive Income & Other	-462	-458	-460	-419	-553	-756
Shareholders' Equity	14,947	14,666	13,432	11,232	12,827	14,440
Total Liabilities & Equity	56,185	57,769	55,356	53,335	53,811	51,248
Total Debt	19,463	19,875	19,646	19,154	16,467	15,109
Net Cash (Debt)	-16,576	-15,113	-15,841	-16,925	-10,539	-6,598
Net Cash Per Share	-36.04	-32.73	-34.23	-36.42	-21.39	-13.06
Filing Date Shares Outstanding	454.37	455.58	461.69	460.36	462.42	498.62
Total Common Shares Outstanding	454.36	455.57	461.68	460.35	471.27	500.88
Working Capital	-1,232	-1,345	-1,806	-1,654	-174	631
Book Value Per Share	32.90	32.19	29.09	24.40	27.22	28.83
Tangible Book Value	14,947	14,035	12,801	10,587	12,171	13,772
Tangible Book Value Per Share	32.90	30.81	27.73	23.00	25.83	27.50
Land	-	6,735	6,547	6,231	6,164	6,141
Buildings	-	36,338	34,853	32,450	30,663	29,503
Machinery	-	12,627	12,193	10,478	8,912	8,679
Construction In Progress	-	1,185	1,703	2,688	1,257	780

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.